Taking cellular immunotherapy to the next level

Glycostem is an innovator in allogeneic cellular immunotherapy using Natural Killer (NK) cells -  oNKord®  - or antigen presenting cells - sDCord® - for treatment of leukemia, lymphoma and solid tumors.

Find out more

About us

Check out the team that is operating at the cutting edge of immunotherapy

Find out more

News

You should not miss this…

Find out more

Technology

The ability to make cancer a chronic disease

Find out more

Products

oNKord® is our lead candidate but we are working on more products

Find out more

Investors

Our mould-breaking and loyal supporters

Find out more

Publications

We share all our articles to promote international cooperation

Find out more